IL80896A0 - Novel synthetic polypeptides - Google Patents

Novel synthetic polypeptides

Info

Publication number
IL80896A0
IL80896A0 IL80896A IL8089686A IL80896A0 IL 80896 A0 IL80896 A0 IL 80896A0 IL 80896 A IL80896 A IL 80896A IL 8089686 A IL8089686 A IL 8089686A IL 80896 A0 IL80896 A0 IL 80896A0
Authority
IL
Israel
Prior art keywords
synthetic polypeptides
novel synthetic
novel
polypeptides
synthetic
Prior art date
Application number
IL80896A
Other languages
English (en)
Original Assignee
University Patents Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26996451&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL80896(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by University Patents Inc filed Critical University Patents Inc
Priority to IL80896A priority Critical patent/IL80896A0/xx
Publication of IL80896A0 publication Critical patent/IL80896A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56994—Herpetoviridae, e.g. cytomegalovirus, Epstein-Barr virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/22—Viral peptide or viral protein
    • Y10S930/224—Herpes related

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
IL80896A 1982-02-18 1986-12-07 Novel synthetic polypeptides IL80896A0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IL80896A IL80896A0 (en) 1982-02-18 1986-12-07 Novel synthetic polypeptides

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US35002182A 1982-02-18 1982-02-18
US06/463,141 US4762708A (en) 1982-02-18 1983-02-04 Materials and methods for herpes simplex virus vaccination
IL67930A IL67930A (en) 1982-02-18 1983-02-16 Immunologically active preparation of herpes simplex virus envelope glycoprotein gd-1 and vaccine composition and diagnostic reagent comprising it
IL80896A IL80896A0 (en) 1982-02-18 1986-12-07 Novel synthetic polypeptides

Publications (1)

Publication Number Publication Date
IL80896A0 true IL80896A0 (en) 1987-03-31

Family

ID=26996451

Family Applications (5)

Application Number Title Priority Date Filing Date
IL80895A IL80895A (en) 1982-02-18 1983-02-16 Immunologically active preparation of herpes simplex virus envelope glycoprotein gd-2 and vaccine composition and diagnostic reagent comprising it
IL67930A IL67930A (en) 1982-02-18 1983-02-16 Immunologically active preparation of herpes simplex virus envelope glycoprotein gd-1 and vaccine composition and diagnostic reagent comprising it
IL80896A IL80896A (en) 1982-02-18 1983-02-16 Synthetic polypeptides which duplicate amino acid sequences of herpes simplex virus envelope glycoproteins and vaccine composition and diagnostic reagent containing them
IL80895A IL80895A0 (en) 1982-02-18 1986-12-07 Material and methods for herpes simplex virus vaccination and diagnosis based on gd-2 glycoprotein
IL80896A IL80896A0 (en) 1982-02-18 1986-12-07 Novel synthetic polypeptides

Family Applications Before (4)

Application Number Title Priority Date Filing Date
IL80895A IL80895A (en) 1982-02-18 1983-02-16 Immunologically active preparation of herpes simplex virus envelope glycoprotein gd-2 and vaccine composition and diagnostic reagent comprising it
IL67930A IL67930A (en) 1982-02-18 1983-02-16 Immunologically active preparation of herpes simplex virus envelope glycoprotein gd-1 and vaccine composition and diagnostic reagent comprising it
IL80896A IL80896A (en) 1982-02-18 1983-02-16 Synthetic polypeptides which duplicate amino acid sequences of herpes simplex virus envelope glycoproteins and vaccine composition and diagnostic reagent containing them
IL80895A IL80895A0 (en) 1982-02-18 1986-12-07 Material and methods for herpes simplex virus vaccination and diagnosis based on gd-2 glycoprotein

Country Status (20)

Country Link
US (1) US4762708A (xx)
EP (1) EP0101506B1 (xx)
JP (3) JP2665332B2 (xx)
KR (1) KR910006889B1 (xx)
AR (1) AR231496A1 (xx)
AT (1) ATE54827T1 (xx)
AU (1) AU554710B2 (xx)
CA (1) CA1236774A (xx)
DE (1) DE3381761D1 (xx)
DK (1) DK172619B1 (xx)
ES (1) ES8406199A1 (xx)
FI (2) FI73885C (xx)
GR (1) GR77900B (xx)
HU (1) HU195734B (xx)
IE (1) IE56479B1 (xx)
IL (5) IL80895A (xx)
NO (2) NO162366B (xx)
NZ (1) NZ220771A (xx)
PH (1) PH25689A (xx)
WO (1) WO1983002897A1 (xx)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4540669A (en) * 1980-09-11 1985-09-10 Merck & Co., Inc. Herpes simplex type I subunit vaccine
US5149660A (en) * 1982-02-18 1992-09-22 University Patents, Inc. Diagnostic reagents relating to herpes simplex virus
US7264817B1 (en) 1983-08-30 2007-09-04 Genentech, Inc. Immunogenic composition based on a truncated derivative of a membrane bound protein and process for making it
NZ209308A (en) * 1983-08-30 1991-08-27 Genentech Inc Vaccine against hsv involving a truncated membrane-free derivative of a membrane-bound protein
NZ209307A (en) * 1983-08-30 1990-07-26 Genentech Inc Diagnostic product: antigenic peptide produced by recombinant dna techniques
JPS6051120A (ja) * 1983-08-31 1985-03-22 Chemo Sero Therapeut Res Inst 単純ヘルペスサブユニットワクチン
US5171568A (en) * 1984-04-06 1992-12-15 Chiron Corporation Recombinant herpes simplex gb-gd vaccine
US5612041A (en) * 1984-07-17 1997-03-18 Chiron Corporation Recombinant herpes simplex gD vaccine
JPS6153226A (ja) * 1984-08-24 1986-03-17 Chemo Sero Therapeut Res Inst 単純ヘルペスサブユニツトワクチンの精製方法
DE3683688D1 (de) * 1985-04-19 1992-03-12 Wistar Inst Impfstoff fuer die erzeugung einer gegen ein virus schuetzenden immunogenen t-zellen-antwort.
GB8605390D0 (en) * 1986-03-05 1986-04-09 Univ Birmingham Live herpes simplex vaccine
EP0471778A1 (en) * 1989-05-12 1992-02-26 Ciba Corning Diagnostics Corp. Herpes simplex virus type 2-glycoprotein g proteins and polypeptides
GB9105992D0 (en) * 1991-03-21 1991-05-08 Smithkline Beecham Biolog Vaccine
US5654174A (en) * 1995-07-07 1997-08-05 Competitive Technologies, Inc. Herpes simplex virus glycoprotein D variants
US20020090382A1 (en) * 2000-08-01 2002-07-11 University Of Pittsburgh Of The Commonwealth System Of Higher Education Antiviral compounds and methods
US20030219448A1 (en) * 2002-05-24 2003-11-27 Cedars-Sinai Medical Center Peptide epitope-based vaccine for treating herpes simplex virus infections and related diseases
DE60324678D1 (de) 2002-07-18 2008-12-24 Univ Washington N t-lymphozyten und damit identifizierte hsv-antigene
US8541002B2 (en) * 2003-09-12 2013-09-24 Agenus Inc. Vaccine for treatment and prevention of herpes simplex virus infection
EP2059255A4 (en) * 2006-09-08 2011-08-31 Univ Pennsylvania VACCINES AGAINST HSV-1 AND HSV-2 AND METHODS OF USE
US8865185B2 (en) * 2006-09-08 2014-10-21 The Trustees Of The University Of Pennsylvania Methods of use for HSV-1 and HSV-2 vaccines
AU2007342345B9 (en) * 2006-12-28 2013-09-12 The Trustees Of The University Of Pennsylvania Herpes Simplex Virus combined subunit vaccines and methods of use thereof
US8057804B2 (en) * 2006-12-28 2011-11-15 The Trustees Of The University Of Pennsylvania Herpes simplex virus combined subunit vaccines and methods of use thereof
US10478490B2 (en) * 2006-12-28 2019-11-19 The Trustees Of The University Of Pennsylvania Herpes simplex virus combined subunit vaccines and methods of use thereof
US20130028925A1 (en) * 2006-12-28 2013-01-31 Harvey Friedman Herpes simplex virus combined subunit vaccines and methods of use thereof
US9089537B2 (en) 2010-02-26 2015-07-28 The Trustees Of The University Of Pennslyvania Subunit vaccines for herpes viruses and methods of use
US20140302062A1 (en) * 2011-04-08 2014-10-09 U.S. Army Medical Research And Materiel Command Herpes simplex virus
EP3388835B1 (en) 2012-05-16 2020-04-01 Immune Design Corp. Vaccines for hsv-2

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4374127A (en) * 1977-09-19 1983-02-15 Merck & Co., Inc. Herpes sub unit vaccine
NO794196L (no) * 1978-12-22 1980-06-24 Biogen Nv Fremgangsmaate ved fremstilling av et rekombinert dna molekyl

Also Published As

Publication number Publication date
ES519875A0 (es) 1984-08-01
AU554710B2 (en) 1986-08-28
FI864102A0 (fi) 1986-10-10
FI833768A (fi) 1983-10-17
IL80896A (en) 1990-02-09
CA1236774A (en) 1988-05-17
EP0101506A4 (en) 1984-07-06
EP0101506B1 (en) 1990-07-25
GR77900B (xx) 1984-09-25
JP2567202B2 (ja) 1996-12-25
AR231496A1 (es) 1984-12-28
KR910006889B1 (ko) 1991-09-10
PH25689A (en) 1991-09-04
DK479083D0 (da) 1983-10-17
NO172745B (no) 1993-05-24
JP2665332B2 (ja) 1997-10-22
FI864102A (fi) 1986-10-10
FI73885B (fi) 1987-08-31
EP0101506A1 (en) 1984-02-29
FI73885C (fi) 1987-12-10
DK479083A (da) 1983-10-17
JPH0769924A (ja) 1995-03-14
US4762708A (en) 1988-08-09
IE56479B1 (en) 1991-08-14
IL67930A (en) 1990-02-09
FI833768A0 (fi) 1983-10-17
FI83880B (fi) 1991-05-31
JPH0797396A (ja) 1995-04-11
IL80895A0 (en) 1987-03-31
ATE54827T1 (de) 1990-08-15
IE830332L (en) 1983-08-18
NO162366B (no) 1989-09-11
JP2669594B2 (ja) 1997-10-29
AU1339683A (en) 1983-09-08
ES8406199A1 (es) 1984-08-01
IL67930A0 (en) 1983-06-15
DE3381761D1 (de) 1990-08-30
DK172619B1 (da) 1999-03-01
NO842962L (no) 1983-10-17
NO833773L (no) 1983-10-17
JPS59500216A (ja) 1984-02-16
WO1983002897A1 (en) 1983-09-01
HU195734B (en) 1988-07-28
KR840003420A (ko) 1984-09-08
IL80895A (en) 1990-02-09
NZ220771A (en) 1990-09-26
FI83880C (fi) 1991-09-10
NO172745C (no) 1993-09-01

Similar Documents

Publication Publication Date Title
IL80896A0 (en) Novel synthetic polypeptides
EP0118617A3 (en) Interleukin-2 polypeptides
GB2120256B (en) Novel peptides
DE3375143D1 (en) Peptides
DE3165244D1 (en) Polypeptides
ZA844857B (en) Novel peptides
GB8327154D0 (en) Polypeptides
GB8319305D0 (en) Synthetic peptides
GB8322529D0 (en) Polypeptides
GB2130590B (en) Peptides
DE3369646D1 (en) Blood-treating material
CS336983A2 (en) Zpusob odstraneni kovove znecisteniny z kapalneho odpadniho proudu
ZA837454B (en) Peptides
ZA816445B (en) Polypeptides
ZA838315B (en) Peptides
CS38283A2 (en) Zpusob odlucovani fenolu z vody
CS201783A1 (en) Zpusob vyroby stavebnichkonstrukci z pevneho silikatoveho betonu
CS200883A1 (en) Zpusob odstraneni cpavku z biochemicky zpracovane prumyslove odpadni vody
GB8329958D0 (en) Materials
GB8306723D0 (en) Materials
IL96581A0 (en) Synthetic polypeptides
GB8306429D0 (en) Synthetic peptides
IE831978L (en) Polypeptides
IE831904L (en) Polypeptides
IE822794L (en) Peptides